Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients

ConclusionThese findings highlight the benefit and practicality of a diagnostic testing program to identify patients suitable for tumour-agnostic TRK inhibitor therapies, as well as other targeted therapies, due to clinically actionable incidental findings identified. Collectively, these findings may inform future guidance on selecting the appropriate testing approach per tumour type and on optimalNTRK testing algorithms.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research